Your browser doesn't support javascript.
loading
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
Varughese, Rahel Sarah; Lam, Walter Sze-Tung; Marican, Ahmad Abdurrahman Bin Hanifah; Viganeshwari, S Hema; Bhave, Anuja Satish; Syn, Nicholas L; Wang, Jigang; Wong, Andrea Li-Ann; Kumar, Alan Prem; Lobie, Peter E; Lee, Soo Chin; Sethi, Gautam; Goh, Boon Cher; Wang, Lingzhi.
Afiliação
  • Varughese RS; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Lam WS; Department of Pharmacology, National University Health System, Singapore.
  • Marican AABH; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Viganeshwari SH; Department of Pharmacology, National University Health System, Singapore.
  • Bhave AS; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Syn NL; Department of Pharmacology, National University Health System, Singapore.
  • Wang J; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Wong AL; Department of Pharmacology, National University Health System, Singapore.
  • Kumar AP; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Lobie PE; Department of Pharmacology, National University Health System, Singapore.
  • Lee SC; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Sethi G; Department of Pharmacology, National University Health System, Singapore.
  • Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Wang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
Cancer ; 125(11): 1789-1798, 2019 06 01.
Article em En | MEDLINE | ID: mdl-30933320
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rotenona / Desenvolvimento de Medicamentos / Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rotenona / Desenvolvimento de Medicamentos / Neoplasias / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article